Psoriatic Arthritis Market Forecasted to Surge in Coming Years, 2023-2032 Analysis by DelveInsight | AbbVie, Novartis, Janssen Research, Sun Pharma, Bristol-Myers Squibb, UCB Biopharma, Affibody AB, Ventyx Biosciences, Aclaris Therapeutics

DelveInsight's "Psoriatic Arthritis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Psoriatic Arthritis, historical and forecasted epidemiology as well as the Psoriatic Arthritis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

To Know in detail about the Psoriatic Arthritis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Psoriatic Arthritis Market Forecast
https://www.delveinsight.com/sample-request/psoriatic-arthritis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Some of the key facts of the Psoriatic Arthritis Market Report:
• The Psoriatic Arthritis market size is estimated to grow approximately USD 15 billion by 2032 with a significant CAGR during the study period (2019-2032)
• Over 1.4 million cases of psoriatic arthritis were reported to be prevalent in the 7MM in 2021, with the United States reporting the largest number of cases.
• There were over 551,000 PsA cases diagnosed in the US in 2021, and over 680,000 cases in the EU-5. During the projected period (2022-2032), there is expected to be an increase in these numbers.
• In September 2022, Significant long-term data from the KEEPsAKE trials demonstrated that over 50% of adult psoriatic arthritis patients treated with Skyrizi (risankizumab, 150mg) achieved a 90% reduction in the Psoriasis Area and Severity Index (PASI 90) and an American College of Rheumatology 20 (ACR20) response at 100 weeks. These results indicate the effectiveness of Skyrizi in treating psoriatic arthritis.
• In September 2022, The United States Food and Drug Administration (USFDA) granted approval to Deucravacitinib, an oral, selective tyrosine kinase 2 (TYK2) inhibitor, for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. This approval represents a significant milestone for the psoriatic arthritis therapeutics market, as Deucravacitinib has the potential to become a new option for patients suffering from this condition.
• Psoriatic Arthritis affected women more than it did men, according to DelveInsight's data. For example, in Japan in 2021, there were about 34,000 cases of Psoriatic Arthritis in males and about 39,000 in females.
• Key Psoriatic Arthritis Companies: Sun Pharma, Bristol-Myers Squibb, UCB Biopharma, Affibody AB, Ventyx Biosciences, Aclaris Therapeutics, AbbVie, Novartis, Janssen Research & Development, LLC, MoonLake Immunotherapeutics AG, and others
• Key Psoriatic Arthritis Therapies: ILUMYA, Deucravacitinib, Bimekizumab, Izokibep, SUNPG18_07, VTX958, ATI-450, Risankizumab, Upadacitinib, AIN457, Ustekinumab, Sonelokimab and others
• The Psoriatic Arthritis epidemiology based on gender analyzed that the prevalence of moderate cases is the highest, followed by severe and mild cases
• The Psoriatic Arthritis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Psoriatic Arthritis pipeline products will significantly revolutionize the Psoriatic Arthritis market dynamics.

Psoriatic Arthritis Overview
Psoriatic arthritis (PsA) is a chronic inflammatory condition that affects some individuals with psoriasis, a skin disease. PsA causes joint pain, stiffness, and swelling, and can also affect other parts of the body, including the skin, nails, and eyes. The exact cause is unknown, but it involves an overactive immune system attacking healthy tissue. Diagnosis typically involves clinical evaluation, imaging, and blood tests.

Get a Free sample for the Psoriatic Arthritis Market Report
https://www.delveinsight.com/report-store/psoriatic-arthritis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Psoriatic Arthritis Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Psoriatic Arthritis Epidemiology Segmentation:
The Psoriatic Arthritis market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
• Total Prevalence of Psoriatic Arthritis
• Prevalent Cases of Psoriatic Arthritis by severity
• Gender-specific Prevalence of Psoriatic Arthritis
• Diagnosed Cases of Episodic and Chronic Psoriatic Arthritis

Download the report to understand which factors are driving Psoriatic Arthritis epidemiology trends @ Psoriatic Arthritis Epidemiology Forecast
https://www.delveinsight.com/sample-request/psoriatic-arthritis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Psoriatic Arthritis Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Psoriatic Arthritis market or expected to get launched during the study period. The analysis covers Psoriatic Arthritis market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Psoriatic Arthritis Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Psoriatic Arthritis Therapies and Key Companies
• ILUMYA: Sun Pharma
• Deucravacitinib: Bristol-Myers Squibb
• Bimekizumab: UCB Biopharma
• Izokibep: Affibody AB
• SUNPG18_07: Sun Pharmaceutical Industries Limited
• VTX958: Ventyx Biosciences, Inc
• ATI-450: Aclaris Therapeutics, Inc.
• Risankizumab: AbbVie
• Upadacitinib: AbbVie
• AIN457: Novartis
• Ustekinumab: Janssen Research & Development, LLC
• Sonelokimab: MoonLake Immunotherapeutics AG

Discover more about therapies set to grab major Psoriatic Arthritis market share @ Psoriatic Arthritis Treatment Market
https://www.delveinsight.com/sample-request/psoriatic-arthritis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Psoriatic Arthritis Market Strengths
• Increased prevalence, growth in awareness, and lifestyle changes have necessitated changes in the diagnosis and treatment of PsA in the recent decade
• Various screening tools, including self-administered questionnaires, have been developed to help dermatologists, rheumatologist, and general physicians to identify patients who might suffer from PsA

Psoriatic Arthritis Market Unmet Needs
• Lack of biomarkers
• Challenges in current treatment options
• Challenges in current guidelines
• Poor disease understanding
• Challenges in managing comorbidities

Scope of the Psoriatic Arthritis Market Report
• Study Period: 2019-2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Psoriatic Arthritis Companies: Sun Pharma, Bristol-Myers Squibb, UCB Biopharma, Affibody AB, Sun Pharmaceutical Industries, Ventyx Biosciences, Aclaris Therapeutics, AbbVie, Novartis, Janssen Research & Development, LLC, MoonLake Immunotherapeutics AG, and others
• Key Psoriatic Arthritis Therapies: ILUMYA, Deucravacitinib, Bimekizumab, Izokibep, SUNPG18_07, VTX958, ATI-450, Risankizumab, Upadacitinib, AIN457, Ustekinumab, Sonelokimab, and others
• Psoriatic Arthritis Therapeutic Assessment: Psoriatic Arthritis current marketed and Psoriatic Arthritis emerging therapies
• Psoriatic Arthritis Market Dynamics: Psoriatic Arthritis market drivers and Psoriatic Arthritis market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Psoriatic Arthritis Unmet Needs, KOL's views, Analyst's views, Psoriatic Arthritis Market Access and Reimbursement

To know more about Psoriatic Arthritis companies working in the treatment market, visit @ Psoriatic Arthritis Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/psoriatic-arthritis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1. Psoriatic Arthritis Market Report Introduction
2. Executive Summary for Psoriatic Arthritis
3. SWOT analysis of Psoriatic Arthritis
4. Psoriatic Arthritis Patient Share (%) Overview at a Glance
5. Psoriatic Arthritis Market Overview at a Glance
6. Psoriatic Arthritis Disease Background and Overview
7. Psoriatic Arthritis Epidemiology and Patient Population
8. Country-Specific Patient Population of Psoriatic Arthritis
9. Psoriatic Arthritis Current Treatment and Medical Practices
10. Psoriatic Arthritis Unmet Needs
11. Psoriatic Arthritis Emerging Therapies
12. Psoriatic Arthritis Market Outlook
13. Country-Wise Psoriatic Arthritis Market Analysis (2019-2032)
14. Psoriatic Arthritis Market Access and Reimbursement of Therapies
15. Psoriatic Arthritis Market Drivers
16. Psoriatic Arthritis Market Barriers
17. Psoriatic Arthritis Appendix
18. Psoriatic Arthritis Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight

Related Reports:

Psoriatic Arthritis Pipeline https://www.delveinsight.com/report-store/psoriatic-arthritis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
"Psoriatic Arthritis Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Psoriatic Arthritis market. A detailed picture of the Psoriatic Arthritis pipeline landscape is provided, which includes the disease overview and Psoriatic Arthritis treatment guidelines.

Psoriatic Arthritis Epidemiology https://www.delveinsight.com/report-store/psoriatic-arthritis-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Psoriatic Arthritis Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Psoriatic Arthritis epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Latest Reports by DelveInsight

Cart-related Neurotoxicity Market https://www.delveinsight.com/report-store/cart-related-neurotoxicity-nt-market
DelveInsight's "CART-related Neurotoxicity Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the CART-related Neurotoxicity, historical and forecasted epidemiology as well as the CART-related Neurotoxicity market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

Crows Feet Market
https://www.delveinsight.com/report-store/crows-feet-market
DelveInsight's "Crows Feet Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Crows Feet, historical and forecasted epidemiology as well as the Crows Feet market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

H3n2 Infection Market
https://www.delveinsight.com/report-store/h3n2-infection-market
DelveInsight's "H3N2 Infection Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the H3N2 Infection, historical and forecasted epidemiology as well as the H3N2 Infection market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Herpes Simplex Virus Market
https://www.delveinsight.com/report-store/herpes-simplex-market
DelveInsight's "Herpes Simplex Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Herpes Simplex, historical and forecasted epidemiology as well as the Herpes Simplex market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Hypercoagulability Market
https://www.delveinsight.com/report-store/hypercoagulability-market
DelveInsight's "Hypercoagulability Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Hypercoagulability, historical and forecasted epidemiology as well as the Hypercoagulability market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Liver Angiosarcoma Market
https://www.delveinsight.com/report-store/liver-angiosarcoma-market
DelveInsight's "Liver Angiosarcoma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Liver Angiosarcoma, historical and forecasted epidemiology as well as the Liver Angiosarcoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Point Of Care Glucose Testing Market
https://www.delveinsight.com/report-store/point-of-care-glucose-testing-market
DelveInsight's 'Point of Care Glucose Testing Market Insight, Competitive Landscape and Market Forecast, 2030' report delivers an in-depth understanding of Point of Care Glucose Testing and the historical and forecasted Point of Care Glucose Testing market trends, globally, which comprises of North America, Europe, APAC, and RoW.

Resorbable Vascular Scaffold Market
https://www.delveinsight.com/report-store/resorbable-vascular-scaffolds-market
DelveInsight's 'Resorbable Vascular Scaffolds - Market Insight, Competitive Landscape, and Market Forecast - 2030' report delivers an in-depth understanding of Resorbable Vascular Scaffolds and the historical and forecasted Resorbable Vascular Scaffolds market trends, globally, which comprises of North America, Europe, APAC, and RoW.

Substance Drug Abuse Market
https://www.delveinsight.com/report-store/substance-drug-abuse-market
DelveInsight's "Substance (Drug) Abuse Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Substance (Drug) Abuse, historical and forecasted epidemiology as well as the Substance (Drug) Abuse market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Trastuzuma Biosimilar
https://www.delveinsight.com/report-store/trastuzumab-biosimilars-insight
DelveInsight's, "Trastuzumab Biosimilar Insight, 2024" report provides comprehensive insights about 35+ companies and 35+ marketed and pipeline drugs in Trastuzumab Biosimilars landscape. It covers the marketed and pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Undifferentiated Pleomorphic Sarcoma Market
https://www.delveinsight.com/report-store/undifferentiated-pleomorphic-sarcoma-market
DelveInsight's "Undifferentiated Pleomorphic Sarcoma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Undifferentiated Pleomorphic Sarcoma, historical and forecasted epidemiology as well as the Undifferentiated Pleomorphic Sarcoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting

About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

This release was published on openPR.